Search
Customer Support

Contact our support team if you have any enquiries about any of our products

Call: (856) 848-8698

Email: info@akersbio.com

In Development: Rapid Breath Test for Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

A single-use, non-invasive device to rapidly screen for chronic obstructive pulmonary disease (COPD), this developmental test will provide results in minutes using patented MPC® Biosensor Technology. The PIFA COPD™ rapid assay is an easy-to-use, rapid screening test for COPD that may help diagnose or rule-out COPD earlier, particularly for patients with less access or willingness to navigate the health system, including access to specialized clinicians such as pulmonologists.

No capital equipment or specialized training is required.

Distributors: Contact Akers Bio to discuss potential distribution opportunities globally (if approved).

Specifications

  • Based on patented Micro Particle Catalyzed (MPC®) Biosensor technology
  • MPC® Biosensor Technology is an exciting development in biomedical science that rapidly determines biomarkers in breath condensate using newly-discovered catalytic agents and microparticles

Note: This test is currently in development